12:00 AM
 | 
Oct 21, 2013
 |  BC Week In Review  |  Company News  |  Other News

Savient, US WorldMeds endocrine/metabolic news

Savient filed for Chapter 11 bankruptcy in the U.S. Bankruptcy Court for the District of Delaware. Savient also entered into an acquisition agreement with neurology company US WorldMeds and its subsidiary Sloan Holdings C.V. whereby Sloan...

Read the full 156 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >